SEARCH RESULT

Total Matching Records found : 700

Redistribution is not inclusion growth by Arvind Panagriya

Only in India does redistribution, which keeps the poor and marginalised out of the mainstream of the economy, pass for inclusive growth. In much of the rest of the world, inclusive growth would mean giving the poor and marginalised a direct stake in the economy with fast-growing industries and services absorbing them into gainful employment and, thus, making them true participants and partners in the growth process.  But in India, we...

More »

Govt to restrict RTI Act applicability by Chetan Chauhan

India’s transparency law – Right To Information – will not change but the government wants to restrict its applicability through other laws. Two new draft laws --- National Sports Development Bill and National Nuclear Safety Authority --- have specific provisions prohibiting disclosing information in addition to the exemption clauses already in the RTI law. Prime Minister Manmohan Singh on Friday wanted a “critical look” at these exemption clauses asking to examine changes...

More »

NCPRI brainstorms Grievance Redress, Whistleblower Protection by Vidya Subrahmanianm

The National Campaign for the People's Right to Information (NCPRI), which — along with other civil society groups — held a two-day convention here on its draft Bills on Grievance Redress and Whistleblower Protection, has urged the government immediately to put up the drafts for wide public consultation. Earlier this year, the NCPRI unveiled a “Basket of Lokpal measures” intended to address corruption and grievances relating to delivery of services. Among...

More »

Affordable medicine

-The Business Standard   It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...

More »

Bitter pill for Big Pharma by Bhupesh Bhandari

A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close